Myriad Genetics Inc $38.01

down 0.00


16/9/2014 04:00 PM  |  NASDAQ : MYGN  
Industries : Diversified Services / Research Services
Get Trend Analysis Icon Get MYGN Trend Analysis - it has outperformed the S&P 500 by 27%

Partner Headlines

  1. Myriad myPath Melanoma Test Reduced Indeterminate Cases By 76% And Changed ...

    Benzinga
  2. Myriad Publishes myRisk Hereditary Cancer Study In Cancer

    Benzinga
  3. FuelCell Upgrade; Amazon Announces New Product

    Benzinga
  4. SeaWorld Drops On Downbeat Results; Canadian Solar Shares Surge

    Benzinga
  5. Myriad Genetics Gets Mixed Analyst Reaction For Q2

    IBD
  6. Markets Rise; Macy's Lowers Comparable Sales Outlook

    Benzinga
  7. Morning Market Losers

    Benzinga
  8. Myriad Genetics Guidance Disappoints, Q4 Edges Views

    IBD
  9. Myriad issues weak guidance

    IBD
  10. Earnings Scheduled For August 12, 2014

    Benzinga
  11. Nasdaq Leads Up Session; Strong Earnings Lift Tata Motors

    IBD
  12. Myriad Genetics' Earnings Face 'Angelina Jolie' Comps

    IBD
  13. Top 4 Stocks In The Research Services Industry With The Highest Profit ...

    Benzinga
  14. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest ...

    Benzinga
  15. Some Stock Leaders Stay Firm Amid Pullback

    IBD
  16. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD
  17. Novo, Other Medicals Display Healthy Action

    IBD
  18. A Few Medical Research Stocks Break Out, Others Basing

    IBD
  19. MYRIAD GENETICS

    IBD
  20. Quiet Session Intensifies As Stocks Hit Session Lows

    IBD
  21. Stocks Extend Losses; AerCap Hits High On Earnings

    IBD
  22. Myriad Genetics and UnitedHealthcare Sign 3 Yr Deal To Make Cancer Tests ...

    Benzinga
  23. Earnings Scheduled For May 6, 2014

    Benzinga
  24. Ubiquiti, Avis Budget Among 5 IBD 50 Stocks Reporting

    IBD
  25. Why I Bought Myriad Genetics (MYGN)

    GuruFocus
  26. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest ...

    Benzinga
  27. Myriad Genetics Is Saving Lives With New Products

    IBD
  28. Analyst Bullish On Medical Research, Equipment Stocks

    IBD
  29. Myriad, Tata Motors Among RS Leaders In Correction

    IBD
  30. UPDATE: Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)

    Benzinga
  31. Avis Budget Leads 5 IBD 50 Stocks Holding Up Well

    IBD
  32. Stocks Jump, Then Trim Gains; Anadarko, Align Rock Ahead

    IBD
  33. Myriad soars to a 5-year high

    IBD
  34. Myriad Gaps Up To High On Reimbursement Rate Change

    IBD
  35. Indexes Extend Win Streak As S&P 500 Marks New High

    IBD
  36. Mid-Afternoon Market Update: MannKind Hangs Onto its Gains as Yelp Shares ...

    Benzinga
  37. Indexes Hold Modest Gains; Under Armour On The Move

    IBD
  38. Mid-Day Market Update: Apollo Drops After Q2 Results; MannKind Shares Spike ...

    Benzinga
  39. Indexes Edge Higher; Rubicon Project Soars In Debut

    IBD
  40. Myriad Genetics Soars On CMS Reimbursement Increase

    IBD
  41. Mid-Morning Market Update: Markets Flat; Monsanto Earnings Beat Street ...

    Benzinga
  42. Benzinga's Volume Movers

    Benzinga
  43. Stocks Whittle Opening Gains; Apollo Tumbles, Despite Upgrade

    IBD
  44. Morning Market Movers

    Benzinga
  45. Jobs Data Trim Stock Futures; Myriad Genetics Spikes

    IBD
  46. J.P. Morgan Reinstates Underweight Rating on Myriad Over LT Outlook Concerns

    Benzinga
  47. Top 4 Stocks In The Research Services Industry With The Lowest PEG Ratio

    Benzinga
  48. Myriad falls on rival product

    IBD
  49. General Motors, Tesla Motors Under Late Pressure

    IBD
  50. Stocks Worsen In Late Trade; Ubiquiti Gains

    IBD
Trading Center